Table 2. Correlation of TROP2 overexpression with conventional clinicopathological parameters.

		TROP2 overexpression
		No	Yes
	Total patients (n)	n (%)	n (%)	P-value
Sex (n=197)
Male	111	51 (46)	60 (54)	0.68
Female	86	37 (43)	49 (57)
Age at diagnosis (n=197)
<65 years	84	37 (44)	47 (56)	0.88
⩾65 years	113	51 (45)	62 (55)
Differentiation (n=181)
Well	24	17 (71)	7 (29)	0.01
Moderate	84	38 (45)	46 (55)
Poor	73	26 (36)	47 (64)
T stage (n=176)
pT1	13	5 (38)	8 (62)	0.06
pT2	52	27 (52)	25 (48)
pT3	80	36 (45)	44 (55)
pT4	31	7 (23)	24 (77)
Lymph node status (n=176)
No	65	34 (52)	31 (48)	0.04
Yes	111	41 (37)	70 (63)
Distant metastasis (n=142)
No	117	56 (48)	61 (52)	0.14
Yes	25	8 (32)	17 (68)
Surgical margin (n=128)
Negative	86	45 (52)	41 (48)	0.10
Positive	42	16 (38)	26 (62)
Stage (UICC) (n=180)
IA	6	4 (67)	2 (33)	0.03
IB	24	15 (63)	9 (37)
IIA	34	15 (44)	19 (56)
IIB	70	32 (46)	38 (54)
III	20	3 (15)	17 (85)
IV	26	9 (35)	17 (64)